Sitagliptin, when combined with standard-of-care drug bevacizumab, is being tested to 1) find out if it is effective at treating gliomas that have returned or …

GliomaGlioblastomaRecurrent Glioma+2 more

~Estimated

~$10 – $7,500

Kailin Yang, MD, PhDNCT07541781

Phase 1

Phase I Study of Replication-Competent Adenovirus-Mediated Double Suicide Gene Therapy With Stereotactic Radiosurgery in Patients With Recurrent or Progressive High Grade Astrocytomas

The primary goal of this Phase I study is to determine the maximum tolerated dose of oncolytic adenovirus mediated double suicide-gene therapy in combination w…

Malignant Glioma of BrainAstrocytomaMalignant Astrocytoma+6 more

~Estimated

~$10 – $6,250

Henry Ford Health SystemNCT05686798